Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Nephrology

Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters

Kidney Failure Clinical Trials

A listing of Kidney Failure medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (98) clinical trials

Patients with kidney disease may ultimately require dialysis therapy. One of the only proven ways to delay dialysis is by controlling blood pressure but many patients with kidney disease still have blood pressure that is too high. The purpose of this study is to evaluate whether patients who participate in ...

Phase N/A

RESTARRT is a clinical research study that is testing whether a combination of several medications can reset the immune system and help it accept a new kidney without the need for life-long immunosuppression. The medications used in RESTARRT are anti-thymocyte globulin (ATG), rituximab, mycophenolate mofetil (MMF), tacrolimus and sirolimus. Participants ...

Phase N/A

Meridien Research needs volunteers for a new clinical trial of a triglyceride-lowering medication. Call Meridien Research today at 813-877-8839 to see if you qualify!

Phase N/A

Effect of Malnutrition on the Prognosis in Hemodialysis Patients

Malnutrition is known to affect their prognosis in hemodialysis patients. Furthermore, recent studies indicate that malnutrition is associated with inflammation and atherosclerosis in these patients. In this study we examine the effect of malnutrition and/or inflammation on atherosclerosis and 5-year survival rate in 600 hemodialysis patients.

Phase N/A

Urinary Marker for Oxidative Stress in Human Cisplatin- Induced Renal Injury

We previously reported early measurement of urinary MDA might be a useful marker for the prediction of CDDP-induced renal damage in rat. The purpose of this clinical study is to test whether the changes of human urinary excretion of MDA, and can be used as early biomarker for the prediction ...

Phase N/A

ADMA Levels in End-Stage Renal Disease

Asymmetric dimethylarginine, ADMA, in plasma, is significantly elevated in patients with renal disease and associated with cardiovascular morbidity and mortality. We found that whole blood (WB) possesses the metabolic pathways required for both the generation and elimination of ADMA and we have developed ex vivo methods to assess the WB ...

Phase N/A

Impact of Different Dialysis on Sleep Apnea in Patients With Renal Failure

Sleep apnea or breathing problems during sleep are frequent, occurring in 6% of the general population. However, more than half of all patients on dialysis suffer from breathing problems related to sleep. Sleep apnea is associated with high blood pressure, excessive sleepiness, fatigue, poor memory and concentration as well as ...

Phase N/A

University of Michigan "Nephrology Research BioBank"

Each year chronic kidney disease (CKD) claims the lives of millions of people worldwide. Costs for patient care are in excess of 2.4 billion dollars in the US alone. At the moment most kidney diseases are of unknown etiology, are classified according to a microscopic description of the kidney tissue ...

Phase N/A

Prevalence of Chronic KIdney Disease in Hypertensive Patients

This will be Cross sectional or prevalent study targeting diagnosed hypertensives aged 40 and above years, in middle to low socio-economic settings of Karachi. This proposed study will be nested in the existing Wellcome Trust funded study. The parent study is designed to determine the impact of a unique community ...

Phase N/A

Assessing Novel Methods of Improving Patient Education of Nutrition

Study Description The relationship between elevated phosphorus levels and morbidity and mortality in patients with chronic kidney disease (CKD) is well recognized, and dietary phosphorus restriction is a mainstay of phosphate management. Despite this, appropriate control of phosphate intake remains sub-par, due in part to the difficulties that patients have ...

Phase N/A